UGT8 antibody (Middle Region)
Quick Overview for UGT8 antibody (Middle Region) (ABIN635705)
Target
See all UGT8 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Middle Region
-
Specificity
- UGT8 antibody was raised against the middle region of µgT8
-
Purification
- Affinity purified
-
Immunogen
- UGT8 antibody was raised using the middle region of µgT8 corresponding to a region with amino acids GILLEWKTVTEKELYEALVKVINNPSYRQRAQKLSEIHKDQPGHPVNRTI
-
-
-
-
Application Notes
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Comment
-
UGT8 Blocking Peptide, (ABIN938722), is also available for use as a blocking control in assays to test for specificity of this µgT8 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of µgT8 antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- UGT8 (UDP Glycosyltransferase 8 (UGT8))
-
Alternative Name
- UGT8
-
Background
- Galactocerebrosides are abundant sphingolipids of the myelin membrane of the central nervous system and peripheral nervous system and are also present in small amounts in kidney. The key enzymatic step in the biosynthesis of galactocerebrosides consists of the transfer of galactose to ceramide catalyzed by UDP-galactose ceramide galactosyltransferase. The enzyme UGT8 is the first involved in complex lipid biosynthesis in the myelinating oligodendrocyte.
-
Molecular Weight
- 61 kDa (MW of target protein)
-
Pathways
- Cell-Cell Junction Organization
Target
-